Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BioMarin Pharmaceuticals Inc (BMRN): Today's Featured Drugs Winner
The Street
Saturday, October 6, 2012 - 11:25am
tags:
Biomarin
Acadia Pharmaceuticals - Breaking Out For A Second Leg Up
Seeking Alpha
Friday, October 5, 2012 - 12:28pm
tags:
Acadia
NICE reverses position on new use for Novartis' Lucentis
Fierce Pharma
Friday, October 5, 2012 - 12:27pm
tags:
NICE, UK, Novartis, Lucentis, diabetic macular edema
Novo to Hire 1,000 People in 2 Years in Emerging Markets
Bloomberg Businessweek
Friday, October 5, 2012 - 12:23pm
tags:
emerging markets, diabetes, Novo Nordisk
Takeda to buy LigoCyte, signs pact with India's Advinus
Pharma Times, UK
Friday, October 5, 2012 - 12:22pm
tags:
Takeda, LigoCyte, India, M&A, Advinus
Insider Sales Case Study: It Is A Deceptive Indicator Of Insider Confidence In A Company
Seeking Alpha
Friday, October 5, 2012 - 12:20pm
tags:
Amarin
Will The Sanofi Pompe Paradigm Play Out With Neuralstem And Lou Gehrig's Disease?
Seeking Alpha
Friday, October 5, 2012 - 12:05pm
tags:
Pompe disease, Sanofi, Neuralstem, Lou Gehrig's disease
FTC Asks Supreme Court To Review Pay To Delay
Pharmalot
Friday, October 5, 2012 - 11:38am
tags:
pay-for-delay, FTC, Supreme Court
Roche Faces New Foe as Boehringer Plans a Rituxan Copy
Bloomberg
Friday, October 5, 2012 - 11:27am
tags:
Roche, Rituxan, Boehringer Ingelheim, rheumatoid arthritis
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Friday, October 5, 2012 - 11:25am
tags:
Bristol-Myers Squibb, Novo Nordisk, Amylin, diabetes
[video]Is Wall Street Turning on Amarin?
Motley Fool
Friday, October 5, 2012 - 11:22am
tags:
Amarin
3 Biotech Stocks That Will Be Making Big Moves
Seeking Alpha
Friday, October 5, 2012 - 11:21am
tags:
Dendreon, MannKind, Spectrum Pharmaceuticals
J&J's $74 Value Hinges On Medical Devices Growth And Pharma Pipeline
Forbes
Friday, October 5, 2012 - 11:20am
tags:
JNJ
New Indication for Abbott's Humira
Yahoo/Zacks
Friday, October 5, 2012 - 11:20am
tags:
Abbott, Humira, ulcerative colitis
This Big Pharma Pair Parts Ways
Motley Fool
Friday, October 5, 2012 - 11:19am
tags:
Sanofi, Bristol-Myers Squibb
Big Pharma to benefit from growth in diabetes: S&P
Marketwatch
Friday, October 5, 2012 - 11:18am
tags:
diabetes, Big Pharma, Eli Lilly, Merck, Bristol-Myers Squibb
Allergan’s Botox Shot Helps Overactive Bladder in Women
Bloomberg
Thursday, October 4, 2012 - 11:06am
tags:
Botox, Allergan, overactive bladder
Endo Health sees weak 2013 profit on generic threat to key drug
Reuters
Thursday, October 4, 2012 - 11:04am
tags:
Endo, generics, lidoderm
3 Interesting Moves In Biotech Stocks From Wednesday
Seeking Alpha
Thursday, October 4, 2012 - 10:58am
tags:
Sarepta, Amarin, Arena Pharmaceuticals, Belviq, Vascepa, eteplirsen
Former FDA chief says J&J broke law promoting Risperdal, Philly Inquirer says
Yahoo/Fly on the Wall
Thursday, October 4, 2012 - 10:55am
tags:
FDA, JNJ, Risperdal

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.